Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 7/20 | 0.53 |
| ▸ | CYP2C8 | P10632 | 3/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.50 |
| ▸ | HTR1A | P08908 | 2/20 | 0.49 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.49 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3340655 | 1.00 | CYP3A4 (0.54) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL3337759 | 0.99 | CYP3A4 (0.52) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL3339105 | 0.90 | CYP3A4 (0.66) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL1586484 | 0.90 | CYP3A4 (0.66) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL3337731 | 0.90 | CYP3A4 (0.66) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL1585862 | 0.90 | CYP3A4 (0.66) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL2207413 | 0.86 | TRPV1 (0.69) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL19126075 | 0.86 | TRPV1 (0.69) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL3111764 | 0.86 | TRPV1 (0.69) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 | |
| SCHEMBL5923303 | 0.86 | TRPV1 (0.69) | CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9399030-B2 | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same | AJINOMOTO CO., INC. (JP) | 2016-07-26 | — | — | US | claimed |
| US-20060287390-A1 | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same | AJINOMOTO CO., INC. (JP) | 2006-12-21 | — | — | US | claimed |
| US-9399030-B2 | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same | AJINOMOTO CO., INC. (JP) | 2016-07-26 | — | — | US | disclosed |
| EP-1853547-B1 | PRODUCTION METHOD OF CAPSINOID BY DEHYDRATING CONDENSATION AND STABILIZING METHOD OF CAPSINOID | AJINOMOTO KK (JP) | 2014-11-12 | — | — | EP | disclosed |
| US-20100152291-A1 | PRODUCTION METHOD OF CAPSINOID BY DEHYDRATING CONDENSATION, STABILIZING METHOD OF CAPSINOID, AND CAPSINOID COMPOSITION | AJINOMOTO CO., INC. (JP) | 2010-06-17 | — | — | US | disclosed |
| US-7700331-B2 | Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition | AJINOMOTO CO., INC. (JP) | 2010-04-20 | — | — | US | disclosed |
| EP-1853547-A1 | PRODUCTION METHOD OF CAPSINOID BY DEHYDRATING CONDENSATION, STABILIZING METHOD OF CAPSINOID, AND CAPSINOID COMPOSITION | Ajinomoto Co., Inc. (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-20070020738-A1 | produced in a high yield in a short time using an enzyme; capsinoid can be stably preserved by coexistence of a fatty acid; enables industrially production | AJINOMOTO CO., INC (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060287390-A1 | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same | AJINOMOTO CO., INC. (JP) | 2006-12-21 | — | — | US | disclosed |
| WO-2006088239-A1 | PRODUCTION METHOD OF CAPSINOID BY DEHYDRATING CONDENSATION, STABILIZING METHOD OF CAPSINOID, AND CAPSINOID COMPOSITION | AJINOMOTO CO., INC. (JP) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287390-A1 | Topically applied circulation enhancing agent and skin and hair cosmetic and bath agent containing the same | CUTA, VEGFA, LIPG | CYP3A4 1221/4885CYP2C9 399/4885CYP2C19 366/4885 |
| US-20100152291-A1 | PRODUCTION METHOD OF CAPSINOID BY DEHYDRATING CONDENSATION, STABILIZING METHOD OF CAPSINOID, AND CAPSINOID COMPOSITION | FADS2, FADS1, FASN | CYP3A4 975/4885CYP2C9 1619/4885CYP2C19 1274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.